U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a new Senate report released by GOP Sen.

The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary Robert F. Kennedy Jr. didn’t have a direct role in the new change, it exemplifies how the vaccine skeptic is reshaping how Americans fight diseases.

The FDA announces changes for who's eligible for the COVID-19 vaccine. Plus, should musicians shut up & sing or tell critics to kick rocks? A PR guru weighs in

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

Two-thirds of Americans believe the Covid-19 virus came out of a lab, and though those numbers have been high for a long time now, low-confidence intelligence assessments have moved in that direction as well.

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the development of the company’s Covid-19 vaccine was purposefully delayed until after the 2020 presidential election.

Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned investment would be one of the biggest in the history of UK life sciences, the Department for Science, Innovation and Technology said.